Financial Performance - For the year ending December 31, 2025, the revenue was RMB 2,795.6 million, a decrease of 4.4% compared to RMB 2,924.5 million for the year ending December 31, 2024[3]. - The gross profit for the year ending December 31, 2025, was RMB 1,207.3 million, an increase of 3.4% from RMB 1,167.8 million for the year ending December 31, 2024[3]. - The profit attributable to owners of the company for the year ending December 31, 2025, was RMB 307.1 million, compared to RMB 297.3 million for the year ending December 31, 2024[3]. - The adjusted EBITDA for the year ending December 31, 2025, was RMB 1,094.5 million, an increase of 3.8% from RMB 1,054.1 million for the year ending December 31, 2024[3]. - The net profit for the year was RMB 383.0 million, an increase from RMB 354.7 million in the previous year[6]. - The company reported a net profit attributable to shareholders of RMB 307,128,000 for 2025, up from RMB 297,321,000 in 2024, reflecting a growth of 3.0%[46]. - The company reported a net loss provision for financial assets of RMB 3,269,000, a decrease from RMB 8,248,000 in the previous year[27]. - The company’s income tax expense increased to RMB 184,311,000 in 2025 from RMB 129,266,000 in 2024, an increase of 42.7%[45]. Assets and Liabilities - The total assets as of December 31, 2025, were RMB 4,878.4 million, compared to RMB 4,858.5 million as of December 31, 2024[10]. - The total equity attributable to owners of the company was RMB 1,646.1 million as of December 31, 2025, compared to RMB 1,345.8 million as of December 31, 2024[10]. - As of December 31, 2025, the group's current liabilities exceeded its current assets by RMB 44,416,000[16]. - The total liabilities related to lease obligations decreased to RMB 1,376,508,000 in 2025 from RMB 1,503,278,000 in 2024, a reduction of 8.4%[12]. - The company has a bank loan of RMB 635,600,000 as of December 31, 2025, down from RMB 797,000,000 in 2024[37]. - Total borrowings decreased to RMB 635.6 million as of December 31, 2025, from RMB 797.0 million in 2024[86]. - Debt-to-equity ratio improved to 33.8% as of December 31, 2025, down from 46.4% in 2024[89]. Revenue Segmentation - For the year ended December 31, 2025, the total revenue was RMB 2,795,553,000, with the integrated hospital segment contributing RMB 441,326,000 and the health check center segment contributing RMB 2,386,267,000[24]. - The comprehensive hospital business generated revenue of RMB 441.3 million in 2025, down 27.6% from RMB 604.4 million in 2024, influenced by the expansion of major public hospitals in the region[63]. - The health check-up business revenue increased by 1.2% to RMB 2,386.3 million in 2025, compared to RMB 2,358.8 million in 2024, driven by growth in the premium service line under the "Xingyuanhui" brand[64]. Operational Metrics - The group provided 294,379 outpatient services during the reporting period, a decrease of 4.2% compared to the previous year, and 25,045 inpatient services, down 14.4%[55]. - The average occupancy rate of the nursing home within the group was 85.0%, an increase from 80.9% in 2024, with an average of 90 residents per day[55]. - The group operates 86 health check centers nationwide as of the end of 2025, up from 83 in 2024, with 79 centers already in operation[56]. Cost Management - The company's selling costs decreased by 9.6% to RMB 1,588.2 million in 2025, down from RMB 1,756.7 million in 2024, due to effective cost control measures[66]. - Administrative expenses fell to RMB 221.4 million in 2025 from RMB 265.1 million in 2024, attributed to ongoing cost reduction initiatives[69]. - The company’s employee benefits expenses decreased to RMB 1,017,085,000 in 2025 from RMB 1,091,246,000 in 2024, a decline of 6.8%[43]. Future Outlook - The company anticipates that the overall market size of China's healthcare services will reach RMB 10.5 trillion by 2025, driven by increasing demand for quality healthcare services[50]. - The company plans to enhance its comprehensive hospital services and aims to establish Nantong Ruici Hospital as a leading tertiary hospital in Nantong within the next 3 to 5 years[60]. - The company intends to leverage the "silver economy" by expanding its rehabilitation and elderly care services, including the completion and opening of the second phase of Ruici Meidi Nursing Home[60]. - The company anticipates that the health service industry will reach a total scale of RMB 16 trillion by 2030, presenting significant opportunities for private healthcare services[60]. Governance and Compliance - The audit committee reviewed the consolidated financial statements for the year ending December 31, 2025, including accounting principles and internal controls[109]. - The company has adopted the corporate governance code as per the listing rules to enhance management and protect shareholder interests[104]. - The board consists of four executive directors and three independent non-executive directors, ensuring a strong independent element[106]. - The company has maintained compliance with the public float requirements set by the Hong Kong Stock Exchange[103].
瑞慈医疗(01526) - 2025 - 年度业绩